ReviewGenes & diseases2027

Influence of oncogenic drivers and signaling pathways on immune checkpoint inhibitor efficacy in NSCLC.

Chunyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.